GlassScriptPhysician profile
Joseph A Mancini
NPI 1417926924
$1,414.13
in general payments reported to CMS, 2019-2025
16 companies · $87.98 in 2025
The $87.98 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $67.61 · 2021: $149 · 2022: $320 · 2023: $347 · 2024: $291 · 2025: $87.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $578.45 | 2019-2025 | Evenity, Prolia |
| Abbvie INC. | $203.98 | 2019-2023 | |
| Astellas Pharma US INC | $152.99 | 2022-2024 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $78.32 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $71.34 | 2019-2022 | |
| Myovant Sciences INC. | $62.34 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $59.87 | 2023-2024 | Myfembree, Gemtesa |
| Daiichi Sankyo INC. | $52.90 | 2019-2024 | Injectafer |
| Allergan, INC. | $27.90 | 2019-2020 | |
| Mycovia Pharmaceuticals, INC. | $22.78 | 2023 | Vivjoa |
| Hologic Sales and Service, LLC | $18.50 | 2023 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $18.49 | 2021 | |
| Agile Therapeutics, INC. | $18.27 | 2022 | |
| Shield Therapeutics INC | $17.11 | 2025 | |
| Sage Therapeutics, LLC | $16.40 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $14.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Mancini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.